TAPI’s portfolio includes over 300 active pharmaceutical ingredients (API) products, making the company an industry leading international supplier of APIs. Though part of Teva Pharmaceutical Industries, TAPI is its own entity, with a history in the generic API industry that dates back over 75 years. TAPI specializes in an array of API-related fields including chemical synthesis, fermentation, chromatography and plant extraction. Headquartered in Israel, TAPI’s state-of-the-art production facilities are located in Italy, Hungary, the Czech Republic, Croatia, Israel, India, China, Mexico, Puerto Rico and the United States.